Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Buddhist Tzu Chi Medical Foundation has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned among 6 distinct examiners and 6 distinct art units, reflecting a fully distributed examination profile in the available data. Counsel should therefore organize prosecution around individual claim sets and references while preserving a common technical narrative where appropriate.
HOLCOMB, MARK is the busiest examiner, with 1 pending action. No examiner carries a larger concentration, so an examiner-focused response program is unlikely to address the portfolio as a whole. Separate review of each art-unit record can help identify the most suitable amendment and interview priorities.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLCOMB, MARK | 1 | 33.4% | +40.0% |
| MCCORMICK, CATHERINE LYNN | 1 | 52.3% | +39.8% |
| NESTOR, DONNA MICHELLE | 1 | 56.6% | +44.2% |
| MOSS, NATALIE M | 1 | 30.7% | +17.2% |
| VISONE, THOMAS J | 1 | 55.6% | +40.2% |
| SIMMONS, CHRIS E | 1 | 34.2% | +19.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19314857 | NURSING CARE INFORMATION SYSTEM | HOLCOMB, MARK | — |
| 18971399 | METHOD FOR SELECTIVE REMOVAL OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS | MCCORMICK, CATHERINE LYNN | — |
| 18954506 | USE OF INDOCYANINE GREEN IN ANTIBACTERIAL OR BACTERICIDAL APPLICATION | NESTOR, DONNA MICHELLE | — |
| 18359053 | METHOD FOR PROMOTING PROLIFERATION AND PLURIPOTENCY FACTOR EXPRESSION OF STEM CELLS AND COMPOSITION PRODUCED USING THE SAME | MOSS, NATALIE M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17378839 | METHOD FOR PREVENTING OR TREATING SKIN DISORDERS AND CONDITIONS | SIMMONS, CHRIS E | 79d overdue |
| 19314857 | NURSING CARE INFORMATION SYSTEM | HOLCOMB, MARK | — |
| 18971399 | METHOD FOR SELECTIVE REMOVAL OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS | MCCORMICK, CATHERINE LYNN | — |
| 18954506 | USE OF INDOCYANINE GREEN IN ANTIBACTERIAL OR BACTERICIDAL APPLICATION | NESTOR, DONNA MICHELLE | — |
| 18359053 | METHOD FOR PROMOTING PROLIFERATION AND PLURIPOTENCY FACTOR EXPRESSION OF STEM CELLS AND COMPOSITION PRODUCED USING THE SAME | MOSS, NATALIE M | — |
| 17821416 | METHOD FOR TREATING OPTIC NEUROPATHY | VISONE, THOMAS J | — |
| Art Unit | Apps |
|---|---|
| 3685 | 1 |
| 1638 | 1 |
| 1627 | 1 |
| 1653 | 1 |
| 1672 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19314857 | NURSING CARE INFORMATION SYSTEM | HOLCOMB, MARK | 3685 | §101§103§112 | Non-Final OA | — | Pending | Aug 29, 2025 |
| 18971399 | METHOD FOR SELECTIVE REMOVAL OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS | MCCORMICK, CATHERINE LYNN | 1638 | §102§103 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18954506 | USE OF INDOCYANINE GREEN IN ANTIBACTERIAL OR BACTERICIDAL APPLICATION | NESTOR, DONNA MICHELLE | 1627 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18359053 | METHOD FOR PROMOTING PROLIFERATION AND PLURIPOTENCY FACTOR EXPRESSION OF STEM CELLS AND COMPOSITION PRODUCED USING THE SAME | MOSS, NATALIE M | 1653 | §102§103 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 17821416 | METHOD FOR TREATING OPTIC NEUROPATHY | VISONE, THOMAS J | 1672 | §103 | Final Rejection | — | Pending | Aug 22, 2022 |
| 17378839 | METHOD FOR PREVENTING OR TREATING SKIN DISORDERS AND CONDITIONS | SIMMONS, CHRIS E | 1622 | §103 | Non-Final OA | 79d overdue | Pending | Jul 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBuddhist Tzu Chi Medical Foundation has 6 pending office actions as of October 2026, spread across 6 art units and 6 examiners.
Mark Holcomb has the most, with 1 of Buddhist Tzu Chi Medical Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
